| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $492.1M | +22.1% |
| R&D Expense | $66.6M | +7.4% |
| SG&A Expense | $125.8M | +16.9% |
| Operating Income | -$7.3M | +66.3% |
| Pre-tax Income | $1.9M | +142.7% |
| Income Tax | -$1.0M | -124.7% |
| Net Income | $2.9M | +133.9% |
| EPS (Basic) | $0.02 | +128.6% |
| EPS (Diluted) | $0.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $495.2M | -24.3% |
| Short-term Investments | $115.8M | — |
| Accounts Receivable | $23.7M | +30.1% |
| Current Assets | $762.9M | -6.5% |
| Total Assets | $1.12B | +4.0% |
| Current Liabilities | $289.8M | +5.8% |
| Total Liabilities | $307.7M | +4.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $91.5M | +13.4% |
| Capital Expenditures | $924K | -8.4% |
| Investing Cash Flow | -$215.8M | -456.5% |
| Financing Cash Flow | -$37.6M | -114.3% |
| Free Cash Flow | $90.5M | +13.7% |
| +128.6% |
| Stockholders' Equity |
| $814.8M |
| +3.6% |